Yu‐Ting Tseng

4.2k citations
89 papers · 3.6k · 2 hit papers · h-index 28

Impact in

Papers in

Yu‐Ting Tseng

82 papers receiving 3.5k citations

Yu‐Ting Tseng's Hit Papers

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 2018 · 313 citations
3130+4+8Years since publication250500750

Peers

Yu‐Ting Tseng
Comparison fields: 5 of 133
  • Cancer Research 589
  • Infectious Diseases 364
  • Molecular Biology 851
  • Complementary and alternative medicine 126
  • Biomaterials 109
Replace Qing Miao with:
Qing Miao China
Lin Zhu China
Dongdong Wu China
Bin Liu China
Yong Tang China
Xinxin Song United States
Adel Mohammed Abuzenadah Saudi Arabia
Chia‐Jung Li Taiwan
Ling Wang China
Yu‐Ting Tseng relative to Qing Miao China Qing Miao's profile →
Citations per field
00.5×1.5×
Qing Miao · 1×
Citations per year

Countries citing papers authored by Yu‐Ting Tseng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ting Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ting Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ting Tseng more than expected).

Fields of papers citing papers by Yu‐Ting Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ting Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ting Tseng. The network helps show where Yu‐Ting Tseng may publish in the future.

Co-authors

The 25 scholars most cited alongside Yu‐Ting Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu‐Ting Tseng Line = papers co-authored together Yu‐Ting Tseng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions
Hit paper breakdown →
2013949
2
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
3 2015218
4 2021134
5 2013125
6 2015118
7 2016100
8 201486
9 201184
10 201777
11 201772
12 201570
13 201663
14 201658
15 202056
16 201248
17 200746
18 201445
19 201845
20 201342

About Yu‐Ting Tseng

Yu‐Ting Tseng is a scholar working on Infectious Diseases, Electronic, Optical and Magnetic Materials, Psychiatry and Mental health, Clinical Biochemistry and Genetics, having authored 89 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Gold and Silver Nanoparticles Synthesis and Applications (8 papers), Nanocluster Synthesis and Applications (5 papers), Neurogenetic and Muscular Disorders Research (4 papers), Advanced Glycation End Products research (4 papers), Schizophrenia research and treatment (4 papers), Bioinformatics and Genomic Networks (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Cancer Research (589 citations), Infectious Diseases (364 citations), Molecular Biology (851 citations), Complementary and alternative medicine (126 citations) and Biomaterials (109 citations). Yu‐Ting Tseng has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yi‐Ching Lo, Chih‐Ching Huang, Huan‐Tsung Chang, Chih‐Hung Chou, Hsi‐Yuan Huang, Ting-Yan Jian, Hsien‐Da Huang, Shu-Yi Ho, Ching-Min Lin and Sheng‐Da Hsu. Their work appears in journals such as Nucleic Acids Research, Phytomedicine, British Journal of Pharmacology, The Lancet and Sensors and Actuators B Chemical.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact